Skip to content

Advertisement

Call for papers – Precision Oncology

Precision oncologyWe are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.

The thematic series is now open for submission of original research and review articles - for further information about this series please click here.

Featured Article: Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection

New Content ItemHepatocellular carcinoma is a common type of liver cancer and is frequently associated with HBV infection. Extensive research into investigating the use of inflammatory indices for prognostic purposes in HBV-related hepatocellular carcinoma has proved controversial and debateable.

In this article, N. Rungsakulkij et al. retrospectively analysed a population of HBV-related hepatocellular carcinoma patients who had undergone hepatic resection to identify whether there were any clinical factors and observations that would be of prognostic value and benefit.

Click here to access the full article.

Aims and scope

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.

The journal welcomes submissions in the pathogen-related cancer areas and other related topics pertinent to the development of therapies for chronic infections and cancer.

Of particular interest are HPV and anogenital cancers (as well as head and neck cancers), EBV and Burkitt lymphoma, HCV/HBV and hepatocellular carcinoma (as well as lymphoproliferative diseases), HHV8 and Kaposi sarcoma, HTLV and leukemia and Cancers in Low- and Middle-income countries.

Please click here for more information.

Articles

  1. Content type: Review

      |  

    Authors: Fernanda Martini, Alfredo Corallini, Veronica Balatti, Silvia Sabbioni, Cecilia Pancaldi and Mauro Tognon

Most accessed articles RSS

View all articles

Article-processing charge discount for AORTIC members

Infectious Agents and Cancer are proudly affiliated with the African Organization for Research and Training in Cancer (AORTIC).  All members of AORTIC receive a 15% discount on the article-processing charge for each article accepted for publication.  This discount can be requested during the submission process and will be verified before being applied.  Standard waiver rules apply for low-income countries.

AORTIC position statement

The African Organization for Research and Training in Cancer (AORTIC) has published a critical appraisal of the state on cancer research and cancer care in Africa including information on the availability of data on cancer burden, screening and prevention for cancer in Africa, cancer care personnel, treatment modalities, and access to cancer care.

Please click here to read the position statement.

Editors-in-Chief

Dr Franco M Buonaguro, Istituto Nazionale Tumori, Naples, Italy

Dr Sam M Mbulaiteye, National Cancer Institute, Bethesda, USA

Please click here to read the Editors' Profiles

Editors' quotes

Dr Franco M. Buonaguro and Dr Sam M Mbulaiteye, Co-Editors-in-Chief of Infectious Agents and Cancer discuss their opinion on the journal's subject field.

FMB

“Cancers related to infectious diseases represent a very significant component of the cancer burden in humans spanning from 20% of all malignancies in industrialized countries to 40% in developing countries. Studies on pathogen-related cancers allow the identification of mechanisms relevant to oncogenesis as well as molecular markers for diagnostic/prognostic methods and targets for therapeutic strategies. Furthermore their relevance is due to the concrete possibility of preventive strategies, which are always cost-effective and can usually be implemented with relatively modest investments. The open access policy of Infectious Agents and Cancer represents a key factor to foster an even participation and contribution by Western as well as Eastern/Southern Countries' colleagues.”

Dr Franco M. Buonaguro, Co-Editor-in-Chief, Infectious Agents and Cancer

SMM

“Cancer is the leading cause of death worldwide. The International Agency for Research on Cancer estimates that about 20% of cancers in developed countries and close to 30% of cancers in developing countries have an infectious etiology. These statistics articulate the imperative to study the epidemiology, biology, and response to treatment of infection-associated cancers to establish sound evidence-based approaches to cancer public policy, prevention, and treatment. The open access policy of Infectious Agents and Cancer represents a key component in the broad efforts to foster, accelerate, and reduce disparity in access to scientific information by scientists, public health authorities, and policy markers worldwide.”

Dr Sam M Mbulaiteye, Co-Editor-in-Chief, Infectious Agents and Cancer

Advertisement

2017 Journal Metrics

Advertisement